These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6459069)

  • 1. Sequential femoropopliteal and femorotibial bypasses. A ten-year follow-up study.
    Rosenfeld JC; Savarese RP; Friedmann P; DeLaurentis DA
    Arch Surg; 1981 Dec; 116(12):1538-43. PubMed ID: 6459069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term value of composite grafts for limb salvage.
    Chang JB; Stein TA
    J Vasc Surg; 1995 Jul; 22(1):25-31. PubMed ID: 7602709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Veterans Administration Cooperative Study Group 141.
    Arch Surg; 1988 Apr; 123(4):434-8. PubMed ID: 3348735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts.
    Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M
    Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite grafts for critical ischaemia.
    Benedetti-Valentini F; Gossetti B; Irace I; Martinelli O; Gattuso R
    Cardiovasc Surg; 1996 Jun; 4(3):372-6. PubMed ID: 8782940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments.
    Kram HB; Gupta SK; Veith FJ; Wengerter KR; Panetta TF; Nwosisi C
    J Vasc Surg; 1991 Sep; 14(3):386-90. PubMed ID: 1880847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.
    Veith FJ; Gupta SK; Ascer E; White-Flores S; Samson RH; Scher LA; Towne JB; Bernhard VM; Bonier P; Flinn WR
    J Vasc Surg; 1986 Jan; 3(1):104-14. PubMed ID: 3510323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revascularization.
    Faries PL; Logerfo FW; Arora S; Pulling MC; Rohan DI; Akbari CM; Campbell DR; Gibbons GW; Pomposelli FB
    J Vasc Surg; 2000 Jun; 31(6):1119-27. PubMed ID: 10842148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term results of 364 femoropopliteal or femorotibial bypasses for revascularization of severely ischemic lower extremities.
    Reichle FA; Tyson RR
    Ann Surg; 1975 Oct; 182(4):449-55. PubMed ID: 126669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value and limitations of secondary femoropopliteal bypasses with polytetrafluoroethylene.
    Yang PM; Wengerter KR; Veith FJ; Panetta TF; Nwosisi C; Gupta SK
    J Vasc Surg; 1991 Sep; 14(3):292-8. PubMed ID: 1880836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene.
    Archie JP
    Ann Vasc Surg; 1994 Sep; 8(5):475-84. PubMed ID: 7811585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.
    Klinkert P; Schepers A; Burger DH; van Bockel JH; Breslau PJ
    J Vasc Surg; 2003 Jan; 37(1):149-55. PubMed ID: 12514593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts.
    Wooster DL; Provan JL; Sojka SG; Madras PN
    Can J Surg; 1982 Nov; 25(6):666-9. PubMed ID: 7139424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femorotibial bypass grafts with sequential technique. Clinical results.
    Jarrett F; Berkoff HA; Crummy AB; Belzer FO
    Arch Surg; 1981 May; 116(5):709-14. PubMed ID: 7235965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The limitations of polytetrafluoroethylene in the reconstruction of femoropopliteal and tibial arteries.
    Hallett JW; Brewster DC; Darling RC
    Surg Gynecol Obstet; 1981 Jun; 152(6):819-21. PubMed ID: 7244961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
    Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
    Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoropopliteal bypass revisited: an analysis of 138 cases.
    Plecha EJ; Freischlag JA; Seabrook GR; Towne JB
    Cardiovasc Surg; 1996 Apr; 4(2):195-9. PubMed ID: 8861436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature.
    Klinkert P; Post PN; Breslau PJ; van Bockel JH
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):357-62. PubMed ID: 15015183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoropopliteal bypass to the isolated popliteal segment: is polytetrafluoroethylene graft acceptable?
    Veith FJ; Gupta SK; Daly VD
    Surgery; 1981 Mar; 89(3):296-303. PubMed ID: 7466617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.